We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » FDA Asks Forest for More Data But No More Trials on Daxas
FDA Asks Forest for More Data But No More Trials on Daxas
May 21, 2010
Forest Laboratories has received an FDA complete response letter to its NDA for Daxas requesting additional information and analyses of the treatment for chronic obstructive pulmonary disease (COPD).